CP4071 in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma

NCT00017446 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

OTHER

Sponsor class

Conditions

Sarcoma

Interventions

DRUG: CP4071

Sponsor

Herbert Irving Comprehensive Cancer Center

Collaborators

[object Object]